Evaluation and follow-up of pain, fatigue, and quality of life in COVID-19 patients

Objectives We evaluated pain, fatigue, anxiety, depression, and quality of life in patients hospitalized for coronavirus disease 2019 (COVID-19) and observed them over a period of 3 months. We also investigated the relationship of these symptoms to age, sex, disease severity, and levels of anxiety and depression. Methods The study included 100 confirmed COVID-19 patients (i.e., positive on a polymerase chain reaction test) between the ages of 18 and 75 years. Pain (visual analog scale [VAS]), fatigue (fatigue severity scale), anxiety, and depression (hospital anxiety and depression scales) were evaluated on the first day of hospitalization and at 1-month and 3-month follow-ups. The short form-12 questionnaire was used to measure quality of life at the 1-month and 3-month follow-ups. Results No differences were found in pain, fatigue, anxiety levels, depression levels, and quality of life according to disease severity. High VAS scores at hospital admission were related to continued pain at the 3-month follow-up (odds ratio [OR], 1.067; p<0.001). High VAS (OR, 1.072; p=0.003) and anxiety levels (OR, 1.360; p=0.007) were related to severe fatigue at the 3-month evaluation. Conclusion Pain, fatigue, anxiety, and depression appear to be long-term sequelae of COVID-19 and can affect quality of life. High VAS and anxiety levels were found to be associated with long-term fatigue

The problem of the antimicrobial drug resistance

Hastane ve toplum kaynaklı infeksiyon etkenlerinde giderek artan antibiyotik direnci önemli bir sorundur. Özellikle Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, Pseudomonas aeruginosa, Acinetobacter spp, metisilin-dirençli Staphylococcus aureus, KNS, vankomisin-dirençli enterococci, Streptococcus pneumoniae ve Mycobacterium tuberculosis gibi mikroorganizmalarda gözlenen direnç tedavide güçlüklere neden olmaktadır. Bu yazıda bu dirençli mikroorganizmaların neden olduğu infeksiyonlarda tedavi yaklaşımları değerlendirilmektedir.Antimicrobial resistance in hospital and community settings is growing at an alarming rate and has been attributed to such organism as Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, Pseudomonas aeruginosa, Acinetobacter spp, methicillin-resistant Staphylococcus aureus, KNS, vancomycin-resistant enterococci, Streptococcus pneumoniae and Mycobacterium tuberculosis. In this article therapeutic approach to infections which occur by multidrug-resistant microorganism were reviewed

The problem of the antimicrobial drug resistance

Hastane ve toplum kaynaklı infeksiyon etkenlerinde giderek artan antibiyotik direnci önemli bir sorundur. Özellikle Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, Pseudomonas aeruginosa, Acinetobacter spp, metisilin-dirençli Staphylococcus aureus, KNS, vankomisin-dirençli enterococci, Streptococcus pneumoniae ve Mycobacterium tuberculosis gibi mikroorganizmalarda gözlenen direnç tedavide güçlüklere neden olmaktadır. Bu yazıda bu dirençli mikroorganizmaların neden olduğu infeksiyonlarda tedavi yaklaşımları değerlendirilmektedir.Antimicrobial resistance in hospital and community settings is growing at an alarming rate and has been attributed to such organism as Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, Pseudomonas aeruginosa, Acinetobacter spp, methicillin-resistant Staphylococcus aureus, KNS, vancomycin-resistant enterococci, Streptococcus pneumoniae and Mycobacterium tuberculosis. In this article therapeutic approach to infections which occur by multidrug-resistant microorganism were reviewed

A Rare Presentation On Ebv Hepatitis

Epstein-Barr virus is a member of Herpesviridae family and it is the cause of infectious mononucleosis (IM) disease. While 50% of the patients having IM have high serum aminotransferases, clinically, a real hepatitis is seen rarely. Presentation of IM with hepatitis clinic without its other symptoms is not a common condition. Jaundice is especially uncommon so it isn&apos;t the presentation symptom generally. When making the differential diagnosis of acute hepatitis, peripheral blood smear examination was crucial, in order toreveal atypical lymphocytes suggesting IM. In this report we presented a patient with icteric IM hepatitis who have atypical lymphocytes on his peripheral blood smear

Acute bacterial meningitis

Akut bakteriyel menenjit (ABM) yüksek oranda mortaliteye neden olabilen ciddi bir infeksiyon hastalığıdır. Bir çok değişik infeksiyöz etken ABM’e yol açar. ABM’de hızlı tanı ve tedavi hayati önem taşır. Bu yazıda değişik yönleri ile ABM’ler gözden geçirilmiştir.Acute bacterial meningitis is a serious infectious disease that may lead to high mortality. The acute bacterial meningitis may be caused by a wide variety of infectious agents. In this infection rapid diagnosis and treatment are very important. In this review acute bacteriel meningitis with different points have been reviewed

Une pharmacie portative à Sorde-l'Abbaye

Julien Pierre. Une pharmacie portative à Sorde-l'Abbaye. In: Revue d'histoire de la pharmacie, 65ᵉ année, n°233, 1977. p. 127

Acute bacterial meningitis

Akut bakteriyel menenjit (ABM) yüksek oranda mortaliteye neden olabilen ciddi bir infeksiyon hastalığıdır. Bir çok değişik infeksiyöz etken ABM’e yol açar. ABM’de hızlı tanı ve tedavi hayati önem taşır. Bu yazıda değişik yönleri ile ABM’ler gözden geçirilmiştir.Acute bacterial meningitis is a serious infectious disease that may lead to high mortality. The acute bacterial meningitis may be caused by a wide variety of infectious agents. In this infection rapid diagnosis and treatment are very important. In this review acute bacteriel meningitis with different points have been reviewed